Bruton's tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis

Carnero Contentti, Edgar; Correale, Jorge

dc.contributor.author	Carnero Contentti, Edgar
dc.contributor.author	Correale, Jorge
dc.date.accessioned	2021-03-18T12:28:08Z
dc.date.available	2021-03-18T12:28:08Z
dc.date.issued	2020-12
dc.identifier.citation	Carnero Contentti, E., Correale, J., 2020. Bruton’s tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis. Expert Opin Emerg Drugs 25, 377–381. https://doi.org/10.1080/14728214.2020.1822817	es_ES
dc.identifier.uri	https://repositorio.fleni.org.ar/xmlui/handle/123456789/382
dc.identifier.uri	https://doi.org/10.1080/14728214.2020.1822817
dc.language.iso	eng	es_ES
dc.publisher	Taylor & Francis	es_ES
dc.rights	info:eu-repo/semantics/openAccess
dc.rights.uri	https://creativecommons.org/licenses/by/2.5/ar/
dc.subject	Multiple Sclerosis	es_ES
dc.subject	Esclerosis Múltiple	es_ES
dc.subject	Agammaglobulinaemia Tyrosine Kinase	es_ES
dc.subject	Agammaglobulinemia Tirosina Quinasa	es_ES
dc.title	Bruton's tyrosine kinase inhibitors: a promising emerging treatment option for multiple sclerosis	es_ES
dc.type	info:eu-repo/semantics/article	es_ES
dc.type	info:eu-repo/semantics/publishedVersion
dc.description.fil	Fil: Carnero Contentti, Edgar. Hospital Alemán de Buenos Aires; Argentina.
dc.description.fil	Fil: Correale, Jorge. Fleni. Departamento de Neurología. Servicio de Neuroinmunología y Enfermedades Desmielinizantes; Argentina.
dc.relation.ispartofVOLUME	25
dc.relation.ispartofNUMBER	4
dc.relation.ispartofPAGINATION	377-381.
dc.relation.ispartofCOUNTRY	Inglaterra
dc.relation.ispartofCITY	Londres
dc.relation.ispartofTITLE	Expert opinion on emerging drugs
dc.relation.ispartofISSN	1744-7623
dc.type.snrd	info:ar-repo/semantics/artículo	es_ES